drug safety

Jödicke, A. M., Tan, E. H., Robinson, D. E., Delmestri, A., & Prieto-Alhambra, D. (2023). Risk of adverse events following the initiation of antihypertensives in older people with complex health needs: a self-controlled case series in the United Kingdom. Age Ageing, 52. http://doi.org/10.1093/ageing/afad177
Domzaridou, E., Carr, M. J., Webb, R. T., Millar, T., & Ashcroft, D. M. (2022). Non-fatal overdose risk during and after opioid agonist treatment: A primary care cohort study with linked hospitalisation and mortality records. Lancet Reg Health Eur, 22, 100489. http://doi.org/10.1016/j.lanepe.2022.100489
Baak, B. N., & Jick, S. S. (2022). Non-steroidal anti-inflammatory drugs and risk of myocardial infarction adjusting for use of proton pump-inhibitors in patients with no major risk factors: a nested case-control study in the UK Clinical Practice Research Datalink. Eur Heart J Cardiovasc Pharmacother. http://doi.org/10.1093/ehjcvp/pvac041
Alkabbani, W., Zongo, A., Minhas-Sandhu, J. K., Eurich, D. T., Shah, B. R., Alsabbagh, M. W., & Gamble, J. M. (2021). Sodium-Glucose Cotransporter-2 Inhibitors and Urinary Tract Infections: A Propensity Score-matched Population-based Cohort Study. Can J Diabetes. http://doi.org/10.1016/j.jcjd.2021.12.005